According to Argus,
ZBH completed an inverse headand-shoulders bottom in mid-Aprilon above-average volume.
On May 2, the stock gapped higher to recovery highs on massive volumefollowing better-than-expected quarterly results. The gap did not hold and over the next four weeks, the shares pulled all the way back
to their 21-month exponential. ZBH then popped back quickly and now is approaching its early May highs.
If the slightly damaged inverse H&S works out, we could see a measured move to $160 or higher, which is not far from the April 2021 all-time high at $170.
Medical device stocks have been in favor since late 2022.
ZBH completed an inverse headand-shoulders bottom in mid-Aprilon above-average volume.
On May 2, the stock gapped higher to recovery highs on massive volumefollowing better-than-expected quarterly results. The gap did not hold and over the next four weeks, the shares pulled all the way back
to their 21-month exponential. ZBH then popped back quickly and now is approaching its early May highs.
If the slightly damaged inverse H&S works out, we could see a measured move to $160 or higher, which is not far from the April 2021 all-time high at $170.
Medical device stocks have been in favor since late 2022.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。